Search

everythinglearnresearchcommunity

for

Search:↓

Conditioned media from mesenchymal stem cell cultures could be a more effective alternative for regenerative therapies, but more research is needed.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

The study established quality standards for Sphagneticola calendulacea stem and suggested it may have therapeutic benefits.

The hydrogel with 20% Hibiscus rosa-sinensis extract was the best for potential therapeutic use.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

The document concludes that understanding how adult stem and progenitor cells move is crucial for tissue repair and developing cell therapies.

Cognitive-behavioral therapy is the best treatment for hair-pulling disorder, and combining it with other therapies could improve results.

The document concludes that regenerating functional ectodermal organs like teeth and hair is promising for future therapies.

Hormonal balance is vital for women's health and performance, but therapies like contraceptives and steroids have both benefits and risks.

The mesenchymal stem cell secretome may effectively treat various diseases as an alternative to traditional stem cell therapies.

The Wnt/β-catenin pathway is important for tissue development and has potential in regenerative medicine, but requires more research for therapeutic use.

The conclusion is that treatments like finasteride and minoxidil can prevent baldness progression and improve hair density, but more research is needed on other therapies.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

PAK4 is crucial in cancer progression, brain development, and could be a therapeutic target, especially through the PAK4-CREB axis.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

New treatments for hair loss show promise but need more testing for effectiveness and safety.

Combination therapies for androgenetic alopecia are more effective, but more research is needed for safe, standardized treatments.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Fat-derived stem cells and their secretions show promise for treating skin aging and hair loss.

New therapies targeting skin neuroimmune interactions could treat neuropathic pain.

RF-based therapies might help treat hair loss.

PDRN, derived from salmon sperm, shows promise in healing wounds, reducing inflammation, and regenerating tissues, but more research is needed to understand its mechanisms and improve its use.

EV-based therapies are advancing but need to overcome challenges for full potential.

Phyla nodiflora contains compounds that may help treat diabetes, hair loss, cancer, and fluid retention.

Mesenchymal stromal cell therapies show promise for treating various diseases but need more research and standardization.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

Hair loss in men and women can be treated with medications and therapies, showing improvement after 6 months.

Repurposing existing drugs can quickly and cheaply find new treatments for diseases.